Literature DB >> 6767508

Recurrent acute hepatitis following the use of factor VIII concentrates.

T J Myers, C L Tembrevilla-Zubiri, A U Klatsky, F R Rickles.   

Abstract

During a 3-yr period, a patient with hemophilia A experienced 5 episodes of acute hepatitis within 7-16 days following 5 separate infusions of factor VIII (FVIII) concentrates. Although the exact mechanism of the recurrent hepatitis remains unclear, these episodes most likely represented repeated allergic reactions to an antigenic protein derived from the FVIII concentrates. Although no evidence was found for a specific humoral immune response to FVIII in the circulation of the patient, an isolated cellular immune response was suggested by the finding of in vitro lymphocyte stimulation in response to the FVIII concentrate. This unusual type of posttransfusion hepatitis must be added to the list of adverse responses to FVIII concentrates.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6767508

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  2 in total

1.  [Hepatitis non-A, non-B: epidemiologic, clinical, serologic and morphologic aspects].

Authors:  H P Spichtin
Journal:  Klin Wochenschr       Date:  1985-05-02

2.  Analysis of contaminants in factor VIII preparations administered to patients with hemophilia.

Authors:  G A Rock; G Farrah; G Rozon; R K Smiley; R Cole; D Villeneuve; P Tittley
Journal:  Can Med Assoc J       Date:  1983-02-15       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.